As the salivary microbiota and IgA responses against it may influence glycemic control, further elucidation of their underlying mechanisms may help in the development of novel diagnostic and therapeutic approaches to reduce the risk of T2DM. The gene discussed is CD79A; the disease is type 2 diabetes mellitus.